CDK1 and vitiligo: With the framework, we had successfully predicted and experimentally validated that some potential therapeutic targets such as CDK1 and PBK were closely related to melanogenesis, and further explored the multi-target strategy of kaempferide for vitiligo through proteomics profiling.